The global veterinary artificial insemination (AI) market is expected to reach USD 11.33 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2030, as per a new report by Grand View Research, Inc. The market's growth is primarily driven by several factors, including the increasing demand for animal protein, the rising need for livestock productivity, and the growing adoption of sexed semen.

One of the significant developments in the market occurred in March 2023, when Genetics Australia, the country's largest supplier of artificial breeding services, announced its merger with URUS, a leading player in the veterinary AI industry. This strategic move will allow Genetics Australia to access global markets, especially for marketing Australian genetics, further boosting the growth of the veterinary AI market.

However, the market has faced challenges due to the COVID-19 pandemic, which caused disruptions in growth, reduced sales and marketing efforts, logistical hurdles, and delays in the delivery of AI services. The unpredictable consumption patterns, exacerbated by lockdowns and logistical bottlenecks, contributed to further market instability. For example, African Swine Fever (ASF) also negatively impacted the market. Companies like Genus experienced labor shortages, declines in retail food service demand, and delays in international logistics during the pandemic, particularly in China and Europe. In North America, there were slowdowns in packing plants during the first half of 2021.

Despite these setbacks, the growing global demand for meat and dairy products has led to an increasing need for effective breeding solutions, prompting market players to expand their artificial insemination services. To meet this demand, companies are innovating and introducing advanced AI solutions to breed high-quality livestock and boost productivity. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for sheep producers in the U.K. Similarly, in September 2021, LIC, an agritech co-operative in New Zealand, launched a sexed semen lab to accommodate the rising demand for artificial insemination services. This innovation allowed LIC to artificially inseminate around 4.5 million cattle during the Spring mating season from September to December 2021.

Get a preview of the latest developments in the Veterinary Artificial Insemination Market? Download your FREE sample PDF copy today and explore key data and trends. 

FAQs for the Global Veterinary Artificial Insemination Market:

1. What is the current size of the veterinary artificial insemination market?

The global veterinary artificial insemination market is estimated to reach USD 11.33 billion by 2030, growing at a CAGR of 6.8% from 2025 to 2030.

2. What are the key factors driving the growth of the veterinary artificial insemination market?

The key drivers include the increasing consumption of animal protein, growing demand for livestock productivity, and the adoption of sexed semen.

3. How has the COVID-19 pandemic affected the veterinary artificial insemination market?

The pandemic caused several challenges, such as reduced sales, supply chain disruptions, labor shortages, and delays in service delivery. Additionally, logistical bottlenecks and consumption pattern changes during lockdowns contributed to market uncertainty.

4. What are some recent developments in the veterinary artificial insemination market?

In March 2023, Genetics Australia merged with URUS, providing access to global markets and Australian genetics. Furthermore, several companies, like LIC and Cogent, have expanded artificial insemination solutions to meet the growing demand for high-quality livestock.

5. How is the adoption of sexed semen contributing to the market?

The growing adoption of sexed semen is helping to improve the productivity of livestock by controlling the sex of the offspring, which is particularly beneficial for dairy and beef farming.

6. How is the veterinary artificial insemination market performing in regions like Latin America?

Latin America, particularly Brazil, has increasingly adopted artificial insemination techniques over the past decade, which is driving market growth in the region. The use of Fixed-Time Artificial Insemination (FTAI) is also increasing in Brazil to improve success rates and profitability.

7. What impact is the demand for meat and dairy products having on the veterinary artificial insemination market?

The growing global demand for meat and dairy products is pushing the need for advanced artificial insemination technologies to breed high-quality livestock and improve production efficiency.

Order a free sample PDF of the Veterinary Artificial Insemination Market Intelligence Study, published by Grand View Research.